Peter D. Suzdak
2017
In 2017, Peter D. Suzdak earned a total compensation of $805.7K as Chief Executive Officer at Rexahn Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $157,500 |
|---|---|
| Option Awards | $135,743 |
| Salary | $450,000 |
| Stock Awards | $46,000 |
| Other | $16,489 |
| Total | $805,732 |
Suzdak received $450K in salary, accounting for 56% of the total pay in 2017.
Suzdak also received $157.5K in non-equity incentive plan, $135.7K in option awards, $46K in stock awards and $16.5K in other compensation.
Rankings
In 2017, Peter D. Suzdak's compensation ranked 9,984th out of 14,666 executives tracked by ExecPay. In other words, Suzdak earned more than 31.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,984 out of 14,666 | 32nd |
Division Manufacturing | 3,862 out of 5,772 | 33rd |
Major group Chemicals And Allied Products | 1,350 out of 2,075 | 35th |
Industry group Drugs | 1,095 out of 1,731 | 37th |
Industry Pharmaceutical Preparations | 856 out of 1,333 | 36th |
Source: SEC filing on April 23, 2018.
Suzdak's colleagues
We found three more compensation records of executives who worked with Peter D. Suzdak at Rexahn Pharmaceuticals in 2017.